Comparative study in the Ames test of benzo[a]pyrene and 2-aminoanthracene metabolic activation using rat hepatic S9 and hepatocytes following in vivo or in vitro induction

Mutagenesis

Volumn 19, Issue 3, 2004, Pages 245-250

  Jemnitz, Katalin ^a   Veres, Zsuzsa ^a   Torok, Geza ^b   Toth, Eva ^b   Vereczkey, Laszlo ^a  

^a CHEMICAL RESEARCH CENTER   (Hungary)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOANTHRACENE; 3 METHYLCHOLANTHRENE; BENZO[A]PYRENE; BETA NAPHTHOFLAVONE; CYTOCHROME P450; ETHOXYRESORUFIN DEETHYLASE; PHENOBARBITAL;

AMES TEST; ANIMAL CELL; ARTICLE; CELL STRAIN; CHEMICAL MUTAGENESIS; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER CELL CULTURE; METABOLIC ACTIVATION; MOLECULAR MODEL; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTHRACENES; BENZO(A)PYRENE; CARCINOGENS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATOCYTES; MALE; MUTAGENICITY TESTS; MUTAGENS; RATS; RATS, WISTAR;

ANIMALIA;

EID: 2942613417     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/geh026     Document Type: Article

References (32)

1. Ames,B.N., McCann,J. and Yamasaki,E. (1975) Methods for determining carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat. Res., 31, 347-364.
2. Bauer,E., Guo,Z., Ueng,Y.F., Bell,L.C., Zeldin,D. and Guengerich,F.P. (1995) Oxidation of benzo(a)pyrene by recombinant human cytochrome P450 enzymes. Chem. Res. Toxicol., 8, 136-142.
3. Bogaards,J.J., Bertrand,M., Jackson,P., Oudshoorn,M.J., Weaver,R.J., van Bladeren,P.J. and Walther,B. (2000) Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica, 30, 1131-1152.
4. Borlak,J. and Thum,T. (2001) Induction of nuclear transcription factors, cytochrome P450 monooxygenases and glutathione S-transferase alpha gene expression in Aroclor 1254-treated rat hepatocyte cultures. Biochem. Pharmacol., 61, 145-153.
5. Burke,M.D., Thompson,S., Elcombe,C.R., Halpert,J., Haaparanta,T. and Mayer,R.T. (1985) Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem. Pharmacol., 34, 3337-3345.
6. Callander,R.D., Mackay,J.M., Clay,P., Elcombe,C.R. and Elliott,B.M. (1995) Evaluation of phenobarbital/β-naphthoflavone as an alternative S9 induction regime to Aroclor 1254 in the rat for use in in vitro genotoxicity assays. Mutagenesis, 10, 517-522.
7. Carriere,V., de Waziers,I., Courtois,Y.A., Leroux,J.-P. and Beaune,P.H. (1992) Cytochrome P450 induction and mutagenicity of 2-aminoanthracene (2AA) in rat liver and gut. Mutat. Res., 268, 11-20.
8. Elliott,B.M., Combes,R.D., Elcombe,C.R., Gatehouse,D.G., Gibson,G.G., Mackay,J.M. and Wolf, R.C. (1992) Alternatives to Aroclor 1254-induced S9 in in vitro genotoxicity assays. Report of UK Environmental Mutagen Society Working Party. Mutagenesis, 7, 175-177.
9. Escobar-Garcia,D., Camacho-Carranza,R., Perez,I., Dorado,V., Arriaga- Alba,M. and Espinosa-Aguirre,J.J. (2001) S9 induction by the combined treatment with cyclohexanol and albenzadole. Mutagenesis, 16, 523-528.
10. Garcia-Franco,S., Dominguez,G. and Pico,J.C. (1999) Alternatives in the induction and preparation of phenobarbital/naphthoflavone-induced S9 and their activation profiles. Mutagenesis, 14, 323-326.
11. Guengerich,F.P., Dannan,G.A., Wright,S.T., Martin,M.V. and Kaminsky,L.S. (1982) Purification and characterization of liver microsomal cytochromes P-450: electrophoretic, spectral, catalytic and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or β-naphthoflavone. Biochemistry, 21, 6019-6030.
12. Hakura,A., Suzuki,S. and Satoh,T. (1999) Advantage of the use of human S9 in the Ames test. Mutat. Res., 438, 29-36.
13. Kranendonk,M., Fisher,C.W., Roda,R., Carreira,F., Theisen,P., Laires,A., Rueff,J., Vermaulen,N.P.E. and Estabrook,R.W. (1999) Escherichia coli MTC, a NADPH cytochrome P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450: comparison of three types of expression systems. Mutat. Res., 439, 287-300.
14. Kranendonk,M., Laires,A., Rueff,J., Estabrook,R.W. and Vermeulen,N.P.E. (2000) Heterologous expression of xenobiotic mammalian-metabolizing enzymes in mutagenicity tester bacteria: an update and practical considerations. Crit. Rev. Toxicol., 30, 287-306.
15. LeCluyse,E., Bullock,P., Madan., Carroll,K. and Parkinson,A. (1999) Influence of extracellular matrix overlay and medium formulation on the induction of cytochrome P-450 2B enzymes in primary cultures of rat hepatocytes. Drug. Metab. Dispos., 27, 909-915.
16. LeCluyse,E., Bullock,P. and Parkinson,A. (1996) Strategies for restoration and maintenance of normal hepatic structure and function in long term cultures of hepatocytes. Adv. Drug Deliv. Rev., 22, 133-186.
17. Lowry,H., Rosebrough,N.J., Farr,A.L. and Randall,R.J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
18. Lubet,R.A., McKinney,C.E., Cameron,J.W., Guengerich,F.P. and Nims,R.W. (1989) Preferential activation of 6-aminochrysene and 2-aminoanthracene to mutagenic moieties by different forms of cytochrome P450 in hepatic 9000 × g supernatants from the rat. Mutat. Res., 212, 275-284.
19. Maron,D.M. and Ames,B.N. (1983) Revised methods for the Salmonella mutagenicity test. Mutat. Res., 113, 173-215.
20. Nebert,D.W. (2002) Transcription factors and cancer: an overview. Toxicology, 181/182, 131-141.
21. Oda,Y., Aryal,P., Terashita,T., Gillam,.M.J., Guengerich,F.P. and Shimada,T. (2001) Metabolic activation of heterocyclic amines and other procarcinogens in Salmonella typhimurium umu tester strains expressing human cytochrome P4501A1, 1A2, 1B1, 2C9, 2D6, 2E1 and 3A4 and human NADPH-P450 reductase and bacterial O-acetyltransferase. Mutat. Res., 492, 81-90.
22. Richert,L., Binda,D., Hamilton,G., Viollon-Abadie,C., Alexandre,E., Bigot-Lasserre,D., Bars,R., Coassolo,P. and LeCluyse,E. (2002) Evaluation of the effect of culture configuration on morphology, survival time, antioxidant status and metabolic capacities of cultured rat hepatocytes. Toxicol. In Vitro, 16, 89-99.
23. Rushmore,T.H. and Kong,A.-N.T. (2002) Pharmacogenomics, regulation and signaling pathways of phase I and phase II drug metabolising enzymes. Curr. Drug Metab., 3, 481-490.
24. Seglen,P.O. (1976) Preparation of isolated rat liver cells. Methods Cell Biol., 13, 29-83.
25. Sparfel,L., Loewert,M., Huc,L., Payen,L., Guillouzo,A., Lagadic-Gossmann,D. and Fardel,O. (2002) Acute cytotoxicity of the chemical carcinogen 2-aminofluorene in cultured rat epithelial cells. Toxicol. Lett., 129, 245-254.
26. Vienneau,D.S., DeBoni,U. and Wells,P.G. (1995) Potential genoprotective role of UDP-glucuronosyltransferases in chemical carcinogenesis: initiation of micronuclei by benzo(a)pyrene and benzo(e)pyrene in UDP-glucuronosyltransferase-deficient cultured rat skin fibroblasts. Cancer Res., 55, 1045-1051.
27. Vogel,H.J. and Bonner,D.M. (1956) Acetylornithinase of E. coli: partial purification and some properties. J. Biol. Chem., 218, 97-106.
28. Wortelboer,H.M., deKruif,C.A., van Iersel,A.A.J., Falke,H.E., Noordhoek,J. and Blaauboer,B.J. (1991) Comparison of cytochrome P450 isoenzyme profiles in rat liver and hepatocyte cultures. Biochem. Pharmacol., 42, 381-390.
29. Yahagi,T., Degawa,M., Seino,Y., Matsushima,T., Nagao,M., Sugimura,T. and hashimoto,y. (1975) Mutagenicity of carcinogenic azo dyes and their derivatives. Cancer Lett., 1, 91-96.
30. Yamazaki,H., Oda,Y., Funae,Y., Imaoka,S., Inui,Y., Guengerich,F.P. and Shimada,T. (1992) Participation of rat liver cytochrome P450 2E1 in the activation of N-nitrosodimethylamine and N-nitrosodiethylamine to product genotoxic in an acetyltransferase-overexpressing Salmonella typhimurium strain (NM2009). Carcinogenesis, 13, 979-985.
31. Zeiger,E., Chhabra,R.S. and Margolin,B.H. (1979) Effects of hepatic S9 fraction from Aroclor-1254-treated rats on the mutagenicity of benzo(a)pyrene and 2-aminoanthracene in the Salmonella/microsomes assay. Mutat. Res., 64, 379-389.
32. Zheng,Z., Fang,J.L. and Lazarus,P. (2002) Glucuronidation: an important mechanism for detoxification of benzo(a)pyrene metabolites in aerodigestive tract tissues. Drug Metab. Dispos., 30, 397-403.